| Literature DB >> 32415190 |
Tito Marcel Lima Santos1, Eduardo Bresciani2, Felipe de Souza Matos3, Samira Esteves Afonso Camargo4, Ana Paula Turrioni Hidalgo5, Luciana Monti Lima Rivera6, Ítalo de Macedo Bernardino7, Luiz Renato Paranhos8.
Abstract
The present study aimed to evaluate the efficiency, effectiveness, and biocompatibility of two agents used for the chemomechanical removal of carious dentin. Sixty extracted carious human teeth were treated with a conventional bur (CBG) or chemomechanical agents - Papacarie Duo (PG) and Brix 3000 (BG). Treatment efficiency and effectiveness were assessed by the working time for carious dentin removal and Knoop microhardness values, respectively. Human pulp fibroblasts (FP6) were used to evaluate cytotoxicity by incorporating MTT dye, and genotoxicity was evaluated with the micronuclei test. The carious tissue was removed in a shorter time with CBG (median = 54.0 seconds) than the time required for chemomechanical agents (p = 0.0001). However, the time was shorter for Brix 3000 (BG) than that for Papacarie Duo (PG), showing mean values of 85.0 and 110.5 seconds, respectively. Regarding microhardness testing, all approaches tested were effective (p < 0.05). The final mean microhardness values were 48.54 ± 16.31 KHN, 43.23 ± 13.26 KHN, and 47.63 ± 22.40 KHN for PG, BG, and CBG, respectively. PG decreased cell viability compared to that of BG, but it presented no genotoxicity. Brix 3000 may be a good option for chemomechanical dentin caries removal due to its reduced removal time and lower cytotoxicity compared to the other treatment options.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32415190 PMCID: PMC7229020 DOI: 10.1038/s41598-020-65159-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Measures of central tendency and the variability of longitudinal microhardness scores according to the specimen groups subjected to the different strategies for carious tissue removal.
| Group | Longitudinal microhardness | Region subjected to carious tissue removal* | Region not subjected to carious tissue removal** | ||||
|---|---|---|---|---|---|---|---|
| Mean (SD) | Median | IQR | Mean (SD) | Median | IQR | ||
| PG(A) | Interface | 40.68 (13.01) | 41.27 | 29.51–51.31 | 23.98 (11.71) | 20.43 | 15.68–32.38 |
| 50 m | 49.21 (15.64) | 50.90 | 34.26–62.53 | 29.82 (14.00) | 28.19 | 16.70–43.11 | |
| 100 m | 51.34 (17.42) | 50.31 | 34.38–65.24 | 36.19 (16.17) | 35.15 | 21.55–50.93 | |
| 150 m | 52.95 (17.17) | 56.68 | 37.47–65.56 | 39.65 (16.82) | 36.44 | 23.75–54.76 | |
| BG(B) | Interface | 36.12 (13.40) | 34.61 | 29.41–46.26 | 22.11 (11.64) | 15.83 | 11.65–35.57 |
| 50 m | 41.17 (12.03) | 43.21 | 33.38–49.45 | 24.80 (13.24) | 18.57 | 15.59–36.59 | |
| 100 m | 46.04 (12.23) | 48.73 | 41.37–55.38 | 28.85 (13.77) | 27.06 | 16.59–42.28 | |
| 150 m | 49.60 (12.19) | 54.32 | 44.36–58.83 | 33.04 (14.53) | 32.37 | 17.76–42.22 | |
| CBG(C) | Interface | 38.60 (11.18) | 37.94 | 28.60–46.51 | 21.24 (11.38) | 18.20 | 10.59–33.27 |
| 50 m | 43.84 (12.17) | 46.29 | 30.03–49.75 | 27.21 (13.51) | 28.38 | 15.02–39.05 | |
| 100 m | 48.29 (12.56) | 47.01 | 39.53–57.43 | 30.62 (14.01) | 32.24 | 19.64–43.78 | |
| 150 m | 59.81 (37.38) | 50.89 | 47.09–61.07 | 34.73 (14.58) | 38.14 | 20.95–47.04 | |
Note. PG = Papacarie Duo; BG = Brix 3000; CBG = conventional bur treatment; SD = standard deviation; IQR = interquartile range (25–75 percentile).
(A)A significant difference in the microhardness scores of the regions subjected/not subjected to the treatment was observed for PPC (Wilcoxon signed-rank test, p < 0.001).
(B)A significant difference in the microhardness scores of the regions subjected/not subjected to the treatment was observed for BRI (Wilcoxon signed-rank test, p < 0.001).
(C)A significant difference in the microhardness scores of the regions subjected/not subjected to the treatment was observed for CBT (Wilcoxon signed-rank test, p < 0.001).
*No significant difference was found among the PPC, BRI, and CBT groups when comparing the microhardness scores in the regions subjected to the treatment (Kruskal-Wallis test, p > 0.05).
**No significant difference was found among the PPC, BRI, and CBT groups when comparing the microhardness scores in the regions not subjected to the treatment (Kruskal-Wallis test, p > 0.05).
Mean differences in microhardness scores using minimally invasive therapies for carious tissue removal, conventional bur treatment, and estimates of effect size (ES).
| Group | Region of longitudinal measuring | Mean score change (SD) | Cohen’s d(a) |
|---|---|---|---|
| PG | Interface | 16.69 (11.73) | 1.43 |
| 50 m | 19.39 (11.07) | 1.39 | |
| 100 m | 15.15 (13.80) | 0.94 | |
| 150 m | 13.30 (14.03) | 0.79 | |
| BG | Interface | 14.00 (14.71) | 1.20 |
| 50 m | 16.37 (14.18) | 1.24 | |
| 100 m | 17.19 (16.71) | 1.25 | |
| 150 m | 16.56 (17.63) | 1.14 | |
| CBG | Interface | 17.36 (12.04) | 1.53 |
| 50 m | 16.62 (14.86) | 1.23 | |
| 100 m | 17.67 (14.07) | 1.26 | |
| 150 m | 25.08 (40.81) | 1.72 | |
Note. PG = Papacarie Duo; BG = Brix 3000; CBG = conventional bur treatment. SD = standard deviation; (a) effect size [ES statistics were calculated by dividing the mean change of microhardness scores by the standard deviation (SD) of the scores observed in the region not subjected to carious tissue removal].
Figure 1Box plot illustrating the differences in time spent (in seconds) for carious tissue removal using different strategies. PPC = Papacarie Duo; BRI = Brix 3000; CBT = conventional bur treatment. Different letters represent statistically significant differences (Kruskal-Wallis test, p < 0.05). This figure has been published within the Master’s Thesis of the first author (T.M.L. Santos), which is available at the Federal University of Sergipe’s digital library of Theses and Dissertations: https://ri.ufs.br/handle/riufs/13164.
Figure 2Percentage of cell viability relative to the mean of the control group in different dilutions of Papacarie Duo. Data are expressed as the mean ± the mean standard deviation. Different letters represent statistically significant differences among dilutions of the same material (ANOVA followed by Tukey’s test, p < 0.05). *Indicates a significant difference between the two materials at the same dilution. This figure has been adapted from the Master’s Thesis of the first author (T.M.L. Santos), which is available at the Federal University of Sergipe’s digital library of Theses and Dissertations: https://ri.ufs.br/handle/riufs/13164.
Figure 3Percentage of cell viability relative to the mean of the control group in different dilutions of Brix 3000. Data are expressed as the mean ± the mean standard deviation. Different letters represent statistically significant differences among dilutions of the same material (ANOVA followed by Tukey’s test, p < 0.05). *Indicates a significant difference between the two materials at the same dilution. This figure has been adapted from the Master’s Thesis of the first author (T.M.L. Santos), which is available at the Federal University of Sergipe’s digital library of Theses and Dissertations: https://ri.ufs.br/handle/riufs/13164.
Mean number of micronuclei found in 2,000 cells.
| Group | Micronuclei mean |
|---|---|
| Papacarie Duo (1:8) | 11a |
| Papacarie Duo (1:16) | 10a |
| Brix 3000 (1:8) | 9a |
| Brix 3000 (1:16) | 8a |
| Positive control (EMS) | 56b |
| Negative control (Cells only) | 7a |
Different letters indicate statistically significant differences (ANOVA followed by Tukey’s test, p < 0.05).